Efficacy of Denosumab for Glucocorticoid-Induced Osteoporosis in an Adolescent Patient with Duchenne Muscular Dystrophy: A Case Report.

Daiki KumakiYukio NakamuraNoriko SakaiTomoki KoshoAkinori NakamuraShinichi HirabayashiTakako SuzukiMikio KamimuraHiroyuki Kato

Published in: JBJS case connector (2019)

To the best of our knowledge, this is the first description of denosumab treatment for glucocorticoid-induced osteoporosis in a patient with DMD. The drug merits additional testing as an effective therapy for osteoporosis in patients with DMD.

Keyphrases

duchenne muscular dystrophy
bone mineral density
postmenopausal women
high glucose
diabetic rats
case report
muscular dystrophy
body composition
drug induced
healthcare
young adults
mental health
giant cell
endothelial cells
oxidative stress
smoking cessation
stress induced